Discovery of a Series of 1,2,3-Triazole-Containing Erlotinib Derivatives With Potent Anti-Tumor Activities Against Non-Small Cell Lung Cancer

New article: Discovery of a Series of 1,2,3-Triazole-Containing Erlotinib Derivatives With Potent Anti-Tumor Activities Against Non-Small Cell Lung Cancer https://t.co/zq4AzBVXU3 #lungcancer #oncology https://t.co/E8M32835nN

New Research: Discovery of a Series of 1,2,3-Triazole-Containing Erlotinib Derivatives With Potent Anti-Tumor Activities Against Non-Small Cell Lung Cancer: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are emerging… https://t.c